Focus Financial Network Inc. lifted its stake in shares of Danaher Co. (NYSE:DHR – Free Report) by 0.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,491 shares of the conglomerate’s stock after acquiring an additional 47 shares during the period. Focus Financial Network Inc.’s holdings in Danaher were worth $2,083,000 at the end of the most recent quarter.
Several other institutional investors have also added to or reduced their stakes in the stock. CarsonAllaria Wealth Management Ltd. acquired a new position in shares of Danaher during the second quarter worth about $25,000. nVerses Capital LLC acquired a new position in Danaher during the 2nd quarter worth approximately $25,000. MFA Wealth Advisors LLC bought a new position in shares of Danaher during the 2nd quarter worth approximately $51,000. Financial Connections Group Inc. acquired a new stake in shares of Danaher in the second quarter valued at approximately $51,000. Finally, Western Pacific Wealth Management LP bought a new stake in shares of Danaher in the first quarter worth $55,000. 79.05% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on the stock. Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price for the company in a research report on Thursday. Stifel Nicolaus lifted their target price on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research report on Wednesday, October 23rd. Royal Bank of Canada reduced their price target on Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research report on Wednesday, October 23rd. Barclays lowered their price target on Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 23rd. Finally, Raymond James cut their price objective on Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $287.16.
Danaher Stock Performance
NYSE:DHR opened at $247.82 on Friday. The stock has a 50 day simple moving average of $266.95 and a 200 day simple moving average of $260.37. The stock has a market cap of $178.99 billion, a P/E ratio of 47.29, a PEG ratio of 4.45 and a beta of 0.83. Danaher Co. has a 1-year low of $190.95 and a 1-year high of $281.70. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32.
Danaher (NYSE:DHR – Get Free Report) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. During the same quarter in the previous year, the business posted $2.02 earnings per share. Danaher’s quarterly revenue was up 3.1% on a year-over-year basis. Research analysts anticipate that Danaher Co. will post 7.51 earnings per share for the current year.
Danaher Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. Danaher’s payout ratio is 20.61%.
Insider Activity at Danaher
In other Danaher news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the transaction, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at $1,130,374.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 11.10% of the stock is currently owned by corporate insiders.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- Manufacturing Stocks Investing
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- Dividend Capture Strategy: What You Need to Know
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.